United Kingdom (UK) AI in Respiratory Diseases Market (2025-2031) | Outlook, Trends, Companies, Share, Size & Revenue, Growth, Competitive Landscape, Analysis, Value, Segmentation, Forecast, Industry

Market Forecast By Indication (Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection), By Imaging Type (MRI, CT Scan, ePRO), By End-use (Hospital, Diagnostic Centers, Ambulatory Surgical centers, Others) And Competitive Landscape
Product Code: ETC9936729 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United Kingdom (UK) AI in Respiratory Diseases Market Outlook
  • Market Size of United Kingdom (UK) AI in Respiratory Diseases Market, 2024
  • Forecast of United Kingdom (UK) AI in Respiratory Diseases Market, 2031
  • Historical Data and Forecast of United Kingdom (UK) AI in Respiratory Diseases Revenues & Volume for the Period 2021- 2031
  • United Kingdom (UK) AI in Respiratory Diseases Market Trend Evolution
  • United Kingdom (UK) AI in Respiratory Diseases Market Drivers and Challenges
  • United Kingdom (UK) AI in Respiratory Diseases Price Trends
  • United Kingdom (UK) AI in Respiratory Diseases Porter's Five Forces
  • United Kingdom (UK) AI in Respiratory Diseases Industry Life Cycle
  • Historical Data and Forecast of United Kingdom (UK) AI in Respiratory Diseases Market Revenues & Volume By Indication for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) AI in Respiratory Diseases Market Revenues & Volume By Chronic Obstructive Pulmonary Disease for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) AI in Respiratory Diseases Market Revenues & Volume By Interstitial Lung Disease for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) AI in Respiratory Diseases Market Revenues & Volume By Pulmonary Infection for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) AI in Respiratory Diseases Market Revenues & Volume By Imaging Type for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) AI in Respiratory Diseases Market Revenues & Volume By MRI for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) AI in Respiratory Diseases Market Revenues & Volume By CT Scan for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) AI in Respiratory Diseases Market Revenues & Volume By ePRO for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) AI in Respiratory Diseases Market Revenues & Volume By End-use for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) AI in Respiratory Diseases Market Revenues & Volume By Hospital for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) AI in Respiratory Diseases Market Revenues & Volume By Diagnostic Centers for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) AI in Respiratory Diseases Market Revenues & Volume By Ambulatory Surgical centers for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) AI in Respiratory Diseases Market Revenues & Volume By Others for the Period 2021- 2031
  • United Kingdom (UK) AI in Respiratory Diseases Import Export Trade Statistics
  • Market Opportunity Assessment By Indication
  • Market Opportunity Assessment By Imaging Type
  • Market Opportunity Assessment By End-use
  • United Kingdom (UK) AI in Respiratory Diseases Top Companies Market Share
  • United Kingdom (UK) AI in Respiratory Diseases Competitive Benchmarking By Technical and Operational Parameters
  • United Kingdom (UK) AI in Respiratory Diseases Company Profiles
  • United Kingdom (UK) AI in Respiratory Diseases Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United Kingdom (UK) AI in Respiratory Diseases Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United Kingdom (UK) AI in Respiratory Diseases Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United Kingdom (UK) AI in Respiratory Diseases Market Overview

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) AI in Respiratory Diseases Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) AI in Respiratory Diseases Market - Industry Life Cycle

3.4 United Kingdom (UK) AI in Respiratory Diseases Market - Porter's Five Forces

3.5 United Kingdom (UK) AI in Respiratory Diseases Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.6 United Kingdom (UK) AI in Respiratory Diseases Market Revenues & Volume Share, By Imaging Type, 2021 & 2031F

3.7 United Kingdom (UK) AI in Respiratory Diseases Market Revenues & Volume Share, By End-use, 2021 & 2031F

4 United Kingdom (UK) AI in Respiratory Diseases Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of respiratory diseases in the UK

4.2.2 Advancements in AI technology leading to better diagnosis and treatment of respiratory diseases

4.2.3 Growing adoption of telemedicine and remote patient monitoring in the healthcare sector

4.3 Market Restraints

4.3.1 High cost of AI technologies and implementation in healthcare settings

4.3.2 Data privacy and security concerns related to AI in healthcare

4.3.3 Lack of skilled professionals to effectively utilize AI technology in respiratory disease management

5 United Kingdom (UK) AI in Respiratory Diseases Market Trends

6 United Kingdom (UK) AI in Respiratory Diseases Market, By Types

6.1 United Kingdom (UK) AI in Respiratory Diseases Market, By Indication

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) AI in Respiratory Diseases Market Revenues & Volume, By Indication, 2021- 2031F

6.1.3 United Kingdom (UK) AI in Respiratory Diseases Market Revenues & Volume, By Chronic Obstructive Pulmonary Disease, 2021- 2031F

6.1.4 United Kingdom (UK) AI in Respiratory Diseases Market Revenues & Volume, By Interstitial Lung Disease, 2021- 2031F

6.1.5 United Kingdom (UK) AI in Respiratory Diseases Market Revenues & Volume, By Pulmonary Infection, 2021- 2031F

6.2 United Kingdom (UK) AI in Respiratory Diseases Market, By Imaging Type

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) AI in Respiratory Diseases Market Revenues & Volume, By MRI, 2021- 2031F

6.2.3 United Kingdom (UK) AI in Respiratory Diseases Market Revenues & Volume, By CT Scan, 2021- 2031F

6.2.4 United Kingdom (UK) AI in Respiratory Diseases Market Revenues & Volume, By ePRO, 2021- 2031F

6.3 United Kingdom (UK) AI in Respiratory Diseases Market, By End-use

6.3.1 Overview and Analysis

6.3.2 United Kingdom (UK) AI in Respiratory Diseases Market Revenues & Volume, By Hospital, 2021- 2031F

6.3.3 United Kingdom (UK) AI in Respiratory Diseases Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F

6.3.4 United Kingdom (UK) AI in Respiratory Diseases Market Revenues & Volume, By Ambulatory Surgical centers, 2021- 2031F

6.3.5 United Kingdom (UK) AI in Respiratory Diseases Market Revenues & Volume, By Others, 2021- 2031F

7 United Kingdom (UK) AI in Respiratory Diseases Market Import-Export Trade Statistics

7.1 United Kingdom (UK) AI in Respiratory Diseases Market Export to Major Countries

7.2 United Kingdom (UK) AI in Respiratory Diseases Market Imports from Major Countries

8 United Kingdom (UK) AI in Respiratory Diseases Market Key Performance Indicators

8.1 Number of AI-powered respiratory disease diagnosis tools being adopted by healthcare facilities

8.2 Percentage increase in the accuracy of AI-based respiratory disease diagnostic systems

8.3 Rate of patient satisfaction with AI-driven respiratory disease management solutions

9 United Kingdom (UK) AI in Respiratory Diseases Market - Opportunity Assessment

9.1 United Kingdom (UK) AI in Respiratory Diseases Market Opportunity Assessment, By Indication, 2021 & 2031F

9.2 United Kingdom (UK) AI in Respiratory Diseases Market Opportunity Assessment, By Imaging Type, 2021 & 2031F

9.3 United Kingdom (UK) AI in Respiratory Diseases Market Opportunity Assessment, By End-use, 2021 & 2031F

10 United Kingdom (UK) AI in Respiratory Diseases Market - Competitive Landscape

10.1 United Kingdom (UK) AI in Respiratory Diseases Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) AI in Respiratory Diseases Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All